Dorsey & Whitney Trust’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $724K | Sell |
15,021
-3,391
| -18% | -$158K | 0.04% | 354 |
|
|
2025
Q4 | $892K | Sell |
18,412
-554
| -3% | -$27.5K | 0.05% | 308 |
|
|
2025
Q3 | $895K | Sell |
18,966
-507
| -3% | -$24.5K | 0.05% | 302 |
|
|
2025
Q2 | $941K | Sell |
19,473
-4,998
| -20% | -$255K | 0.05% | 285 |
|
|
2025
Q1 | $1.36M | Buy |
24,471
+348
| +1% | +$18.8K | 0.08% | 220 |
|
|
2024
Q4 | $1.16M | Sell |
24,123
-390
| -2% | -$19.8K | 0.06% | 236 |
|
|
2024
Q3 | $1.41M | Buy |
24,513
+912
| +4% | +$49.2K | 0.08% | 208 |
|
|
2024
Q2 | $1.15M | Buy |
23,601
+886
| +4% | +$42.7K | 0.08% | 205 |
|
|
2024
Q1 | $1.1M | Buy |
22,715
+547
| +2% | +$26.7K | 0.08% | 208 |
|
|
2023
Q4 | $1.1M | Sell |
22,168
-727
| -3% | -$35.5K | 0.08% | 203 |
|
|
2023
Q3 | $1.23M | Buy |
22,895
+473
| +2% | +$25.2K | 0.11% | 173 |
|
|
2023
Q2 | $1.21M | Buy |
22,422
+59
| +0.3% | +$3.17K | 0.1% | 186 |
|
|
2023
Q1 | $1.22M | Buy |
22,363
+484
| +2% | +$23.5K | 0.11% | 173 |
|
|
2022
Q4 | $1.06M | Buy |
21,879
+2,085
| +11% | +$91.5K | 0.1% | 185 |
|
|
2022
Q3 | $752K | Buy |
19,794
+2,455
| +14% | +$109K | 0.08% | 225 |
|
|
2022
Q2 | $867K | Buy |
17,339
+780
| +5% | +$41.4K | 0.09% | 205 |
|
|
2022
Q1 | $851K | Buy |
16,559
+690
| +4% | +$35.6K | 0.07% | 227 |
|
|
2021
Q4 | $794K | Buy |
15,869
+63
| +0.4% | +$3.12K | 0.07% | 235 |
|
|
2021
Q3 | $761K | Buy |
15,806
+50
| +0.3% | +$2.54K | 0.07% | 225 |
|
|
2021
Q2 | $829K | Sell |
15,756
-6,350
| -29% | -$331K | 0.08% | 208 |
|
|
2021
Q1 | $1.09M | Sell |
22,106
-275
| -1% | -$13.2K | 0.11% | 182 |
|
|
2020
Q4 | $1.09M | Buy |
22,381
+25
| +0.1% | +$1.23K | 0.13% | 154 |
|
|
2020
Q3 | $1.12M | Buy |
22,356
+275
| +1% | +$14.2K | 0.15% | 145 |
|
|
2020
Q2 | $1.13M | Buy |
22,081
+112
| +0.5% | +$5.44K | 0.16% | 144 |
|
|
2020
Q1 | $961K | Buy |
21,969
+138
| +0.6% | +$6.6K | 0.16% | 136 |
|
|
2019
Q4 | $1.09M | Hold |
21,831
| – | – | 0.15% | 138 |
|
|
2019
Q3 | $1.01M | Hold |
21,831
| – | – | 0.15% | 137 |
|
|
2019
Q2 | $945K | Sell |
21,831
-388
| -2% | -$16.5K | 0.15% | 140 |
|
|
2019
Q1 | $984K | Buy |
22,219
+2,996
| +16% | +$128K | 0.15% | 129 |
|
|
2018
Q4 | $835K | Sell |
19,223
-212
| -1% | -$9.35K | 0.15% | 135 |
|
|
2018
Q3 | $867K | Buy |
19,435
+500
| +3% | +$21.4K | 0.13% | 132 |
|
|
2018
Q2 | $757K | Buy |
18,935
+5,854
| +45% | +$230K | 0.13% | 142 |
|
|
2018
Q1 | $525K | Buy |
13,081
+1,228
| +10% | +$51.1K | 0.1% | 163 |
|
|
2017
Q4 | $510K | Sell |
11,853
-3,732
| -24% | -$172K | 0.09% | 160 |
|
|
2017
Q3 | $775K | Hold |
15,585
| – | – | 0.15% | 112 |
|
|
2017
Q2 | $747K | Hold |
15,585
| – | – | 0.15% | 118 |
|
|
2017
Q1 | $706K | Buy |
+15,585
| New | +$661K | 0.14% | 122 |
|
|
2014
Q4 | – | Sell |
-9,074
| Closed | -$512K | – | 265 |
|
|
2014
Q3 | $512K | Buy |
9,074
+37
| +0.4% | +$1.99K | 0.14% | 131 |
|
|
2014
Q2 | $480K | Hold |
9,037
| – | – | 0.1% | 137 |
|
|
2014
Q1 | $472K | Buy |
+9,037
| New | +$457K | 0.11% | 129 |
|
Other funds holding SNY
MIP
Dorsey & Whitney Trust's SNY Position: Q1 2026 in Review
Dorsey & Whitney Trust reduced its Sanofi (SNY) stake by 18% in Q1 2026, selling an estimated $158K and leaving 15,021 shares worth $724K. The position accounts for 0.04% of the portfolio, ranked #354.
Dorsey & Whitney Trust first reported a position in SNY in Q1 2014 and has held it in 40 quarters since. The position peaked at $1.41M in Q3 2024. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Dorsey & Whitney Trust held 15,021 shares of Sanofi worth $724K as of Q1 2026.
- Dorsey & Whitney Trust sold 3,391 Sanofi shares in Q1 2026, an estimated $158K.
- Sanofi made up 0.04% of Dorsey & Whitney Trust's portfolio in Q1 2026, its #354 holding.
- Dorsey & Whitney Trust first reported a position in Sanofi in Q1 2014 and has held it in 40 quarters since.
- Dorsey & Whitney Trust's Sanofi position peaked at $1.41M in Q3 2024.
- 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.